IP Library Granted Patent US 7,470,686
Granted Patent B2
US 7,470,686 · App. 11/779,585 · Granted Dec 30, 2008

Method of inhibiting the expression and/or the activity of JNK

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,470,686
App. No.
11/779,585
Granted
Dec 30, 2008
Kind
B2
Abstract

The present invention is related to benzazole derivatives notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such benzazole derivatives. Said benzazole derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK2 and/or 3. The present invention is furthermore related to novel benzazole derivatives as well as to methods of their preparation. X is O, S or NR 0 , with R 0 being H or an unsubstantiated or substituted C 1 -C 6 alkyl; G is an unsubstantiated or substituted pyrimidinyl group.

Claims (125)

1. A method for treating rheumatoid arthritis, comprising administering to a patient in need thereof a benzothiazole compound according to formula I

as well as its automats, its geometrical isomers, its optically active forms as enantiomers, diastereomers and its racemate forms, or pharmaceutically acceptable salts thereof, wherein:

G is an unsubstantiated or substituted pyrimidinyl group;

R 1 is selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, optionally substituted by halogen; and

R 2 is hydrogen.

2. The method of claim 1 , wherein the benzothiazole compound is a benzothiazole compound according to formula I, as well as its automats according to formula II below,

its geometrical isomers, its optically active forms as enantiomers, diastereomers and their racemate forms, or pharmaceutically acceptable salts thereof.

3. The method of claim 1 , wherein, in the benzothiazole compound, G is a pyrimidinyl group

L is selected from the group consisting of hydrogen, unsubstantiated or substituted C 1 -C 6 alkyl, unsubstantiated or substituted C 1 -C 6 alkoxy, unsubstantiated or substituted C 1 -C 6 thioalkoxy, unsubstantiated or substituted C 2 -C 6 alkenyl, unsubstantiated or substituted C 2 -C 6 alkynyl, primary, secondary or tertiary amino groups, aminoacyl, aminocarbonyl, amino -(C 1 -C 10 ) alkyl, amino -unsubstantiated or substituted (C 1 -C 10 ) -alkyl -aryl, amino -unsubstantiated or substituted (C 1 -C 10 )alkyl -heteroaryl, unsubstantiated or substituted C 1 -C 6 alkoxycarbonyl, carboxyl, cyano, halogen, hydroxyl, nitro, sulfoxy, sulfonyl, unsubstantiated or substituted aryl, unsubstantiated or substituted heteroaryl, unsubstantiated or substituted 3-8 membered cyclically, optionally containing at least one heteroatom selected from N, O, S, and unsubstantiated or substituted hydracids groups, wherein the term “substituted” means that said groups can be substituted with from 1 to 5 substituents selected from the group consisting of C 1 -C 6 -alkyl, C 1 -C 6 -alkyl aryl, C 1 -C 6 -alkyl heteroaryl, C 2 -C 6 -alkenyl, C2-C6-alkynyl, primary, secondary or tertiary amino groups or quarternary ammonium moieties, acryl, acyloxy, calamine, aminocarbonyl, alkoxycarbonyl, aryl, heteroaryl, carboxyl, cyano, halogen, hydroxyl, mercapto, nitro, sulfoxy, sulfonyl, alkoxy, thioalkoxy, and trihalomethyl; and

said substitution may optionally include situations where neighboring substituents have undergone ring closure wherein said substituents form lactase, lactones, cyclic anhydrides, acetyls, thioacetals, or ammonals formed by ring closure.

4. The method of claim 3 , wherein, in the benzothiazole compound, L is a group —N(R a , R b ) or —OR a , with R a and R b being each independently selected from the group consisting of H, unsubstantiated or substituted (C 1 -C 10 ) -alkyl, unsubstantiated or substituted C 1 -C 6 alkyl -aryl, unsubstantiated or substituted C 1 -C 6 -alkyl -heteroaryl, unsubstantiated or substituted aryl, heteroaryl and unsubstantiated or substituted 4-8 membered saturated or unsaturated cycloalkyl.

5. The method of claim 4 , wherein, in the benzothiazole compound, L is selected from

where n is 1 to 10, and

R 5 and R 5 ′ are independently selected from each other from the group consisting of H, substituted or unsubstantiated C 1 -C 10 alkyl, substituted or unsubstantiated aryl or heteroaryl, substituted or unsubstantiated C 1 -C 6 alkyl -aryl and substituted or unsubstantiated C 1 -C 6 -alkyl -heteroaryl.

6. The method of claim 5 , wherein, in the benzothiazole compound, n is 1 to 6.

7. The method of claim 5 , wherein, in the benzothiazole compound, R 1 is H.

8. The method of claim 1 , wherein, in the benzothiazole compound, R 1 is hydrogen, G is a pyrimidinyl group

with L being either

where n is 0, 1 or 2 and R 5 is an aryl or heteroaryl.

9. The method of claim 8 , wherein, in the benzothiazole compound, R 5 is phenyl, pyridyl, or imidazolyl.

10. The method of claim 1 , wherein the benzothiazole compound is selected from the following group:

1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl (2, 6-dimethoxy -4 pyrimidinyl) acetonitrile;

1,3-benzothiazol-2-yl (2-chloral -6-methyl -4 -pyrimidinyl) acetonitrile;

1,3-benzothiazol-2-yl [2 -(methylsulfanyl) - 4 -pyrimidinyl] acetonitrile;

1,3-benzothiazol-2-yl{6-chloral -5-nitro -4 -pyrimidinyl }acetonitrile;

1,3-benzothiazol-2-yl(2-hydroxyl -pyrimidinyl -4-yl) acetonitrile;

(2-chloropyrimidin-4-yl)[5-(trifluoromethyl) -1, 3-benzothiazol-2-yl]acetonitrile;

(2E) -(2-chloral -4-pyrimidinyl)(3-methyl -1, 3-benzothiazol-2(3H) -ylidene)ethanenitrile;

1,3-benzothiazol-2-yl(2-{[2-(1H -imidazol -5-yl)ethyl]amino}-4-pyrimidinyl) -acetonitrile;

1,3-benzothiazol-2-yl[2 -(1-piperazinyl) -4 -pyrimidinyl]acetonitrile;

1, 3-benzothiazol-2-yl[2-(4-benzyl -1-piperidinyl) -4-pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl[2 -(4-methyl -1-piperazinyl) -4 -pyrimidinyl ]acetonitrile;

1,3-benzothiazol-2-yl[2 -(4-morpholinyl) -4 -pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl[2-(methylamine) -4 -pyrimidinyl ]acetonitrile;

1,3- benzothiazol-2-yl(2-{4-[2-(4-morpholinyl) ethyl]-1 -piperazinyl}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl{2-[4 -(benzyloxy) -1-piperidinyl ]-4-pyrimidinyl }acetonitrile;

1,3-benzothiazol-2-yl[2-(4-hydroxyl -1-piperidinyl) -4-pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl(2-hydrazine -4-pyrimidinyl) acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(dimethylamino)ethyl ]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl[2-(dimethylamino) - 4-pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-methoxyethyl) amino ]-4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-hydroxyethyl) amino]4 -pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl[2-(propylamino) -4 -pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl(2-{[3-(1H -imidazol -1-yl)propyl ]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl[2-(1-pyrrolidinyl) - 4 -pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-phenylethyl) amino]-4-pyrimidinyl-}acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(2-pyridinyl) ethyl]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-pyridinylmethyl)amino]-4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl{2 -[4-(1H -1,2,3-benzotriazol -1-yl) -1-piperidinyl]-4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl{2-[4-(2-pyrazinyl) -1-piperazinyl]-4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl{2 -[4 -(2-pyrimidinyl) -1piperazinyl]-4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl(5-bromo -2{[2-(dimethylamino) ethyl]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-morpholin -4-ylethyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl[2-(4-{3-[(trifluoromethyl) sulfonyl]anilino}piperidin -1-yl)pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl(2-{[3-(2-oxopyrrolidin -1-yl) propyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{methyl[3-(methylamino) propyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[3-(4-methylpiperazin1 -yl) propyl]amino}pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl{2-[(3-morpholin -4-ylpropyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(1-methyl -1H -imidazol -4 -yl) ethyl]amino}pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(1H -indol -3 -yl) ethyl]amino }pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(4 -hydroxyphenyl) ethyl]amino}pyrimidin-4-yl) acetonitrile;

tert -butyl({4-[1,3-benzothiazol-2-yl (cyano)methyl]pyrimidin-2-yl}amino)acetate {2-[(3-aminopropyl)amino]pyrimidin-4-yl}(1,3-benzothiazol-2 -yl) acetonitrile;

{-2[(2-aminoethyl)amino]pyrimidin-4-yl}(1,3-benzothiazol-2 -yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[3 -(dimethylamino) propyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-piperidin -1 -ylethyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(1-methyl -1H -imidazol -5 -yl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl[2-(benzylamino) pyrimidin-4-yl]acetonitrile; isopropyl3-({4-[1,3-benzothiazol-2 -yl (cyano)methyl]pyrimidin-2-yl}amino)propionate

1,3-benzothiazol-2-yl{2-[(3-hydroxypropyl)amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl{2-[(pyridine-3 -ylmethyl) amino]pyrimidin-4-yl}acetonitrile; (2-aminopyrimidin-4-yl)(1,3-benzothiazol-2-yl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(pyridine-4-ylmethyl) amino]pyrimidin-4-yl}acetonitrile;

tert -butyl4-[2-({4-[1,3-benzothiazol-2-yl (cyano)methyl]pyrimidin-2-yl}amino)ethyl]phenylcarbamate (2-{[2-(4-aminophenyl)ethyl]amino}pyrimidin-4-yl) (1,3-benzothiazol-2-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(3,4-dimethoxyphenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(3 methoxyphenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(2 -fluorophenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl[2-({2-[3-(trifluoromethyl) phenyl]ethyl}amino)pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-hydroxyl -2phenylethyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol2-yl{2[(2{[3 (trifluoromethyl)pyridin2 yl]amino}ethyl)amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl(2{[2(3 chiorophenyl) ethyl]amino }pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl(2{[2(3,4 dichlorophenyl) ethyl]amino }pyrimidin-4-yl) acetonitrile; 1,3-benzothiazol-2-yl(2{[2(4 methoxyphenyl) ethyl]amino }pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl(2{[2(4 methylphenyl) ethyl]amino }pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl(2{[2(3 fluorophenyl) ethyl]amino }pyrimidin-4-yl) acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(4 -phenoxyphenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(2 -phenoxyphenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

l,3-benzothiazol-2-yl(2-{[2-(4 -bromophenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(4 -fluorophenyl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-[1,1′-biphenyl]-4-ylethyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl{2[(2{4 [hydroxyl(oxide)amino]phenyl}ethyl)amino]pyrimidin-4- yl }acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(1H -1,2,4-triazol -1-yl) ethyl]amino}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl(2-{[3-(1H -pyrazol1-yl) propyl]amino}pyrimidin-4-yl)acetonitrile;

4[2-({4-[1,3-benzothiazol-2-yl(cyano)methyl]pyrimidin-2-yl}amino)ethyl]benzene sulfonamide {2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}[5-(trifluoromethyl) -1,3-benzothiazol-2-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(1H -tetraazol -5 -ylmethyl) amino]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl[2-(benzyloxy)pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(4-pyridin-3-ylbenzyl) oxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl[2-(pyridin-4-ylmethoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl[2-(pyridin-2-ylmethoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl[2-(3-pyridin-2-ylpropoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(4-methoxybenzyl)oxy]pyrimidin-4-yl }acetonitrile;

1,3-benzothiazol-2-yl[2-(pyridin-3-ylmethoxy)pyrimidin-4-yl]acetonitrile;

1, 3-benzothiazol-2-yl{2-[2-(4-methoxyphenyl)ethoxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl[2-([1,1′-biphenyl]-3-ylmethoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(3,4,5-trimethoxybenzyl) oxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl{2-[(3,4-dichlorobenzyl)oxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl[2-({3-[(dimethylamino)methyl]benzyl}oxy)pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(1-oxidopyridin-3-yl) methoxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl(2-{[4-(morpholin -4-ylmethyl) benzyl]oxy}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl{2-[(4-pyridin-2-ylbenzyl) oxy]pyrimidin-4-yl}acetonitrile;

1,3-benzothiazol-2-yl(2-{[4-(piperidin -1-ylmethyl) benzyl]oxy}pyrimidin-4-yl)acetonitrile;

1,3-benzothiazol-2-yl [2-(4-methoxyphenoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl[2-(4-butoxyphenoxy) pyrimidin-4-yl]acetonitrile;

{2-[4-(4-acetylpiperazin -1-yl)phenoxy]pyrimidin-4-yl}(1,3-benzothiazol-2-yl)acetonitrile;

[2-(4-methoxyphenoxy)pyrimidin-4-yl][5-(trifluoromethyl) -1,3-benzothiazol-2-yl]acetonitrile;

1,3-benzothiazol-2-yl(pyrimidin-4-yl)acetonitrile; and N -[2-({4-[1,3-benzothiazol-2-yl(cyano)methyl]pyrimidin-2-yl}amino)ethyl]-4-chlorobenzamidel,3-benzothiazol-2-yl (2-methoxy -4-pyrimidinyl)acetonitrile.

11. The method of claim 10 , wherein the benzothiazole compound is selected from the group consisting of:

1,3-benzothiazol-2-yl(2-chloro -4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl[2-(methylsulfanyl) -4-pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl(2-{[2-(1H -imidazol -5-yl)ethyl]amino}-4-pyrimidinyl)acetonitrile;

1,3-benzothiazol-2-yl[2-(methylamino) -4 pyrimidinyl]acetonitrile;

1,3-benzothiazol-2-yl{2-[(2-hydroxyethyl) amino]4-pyrimidinyl}acetonitrile;

1,3-benzothiazol-2-yl[2-(benzyloxy)pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl[2-(4-methoxyphenoxy) pyrimidin-4-yl]acetonitrile;

1,3-benzothiazol-2-yl (2-methoxy -4-pyrimidinyl)acetonitrile; and

1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4-pyrimidinyl)acetonitrile.

12. The method of claim 1 , wherein the benzothiazole compound is 1,3-benzothiazol-2-yl ([2-{[4-(morpholin -4-ylmethyl)benzyl]oxy}-pyrimidin-4-yl) acetonitrile.

Assignments (2)
CHANGE OF NAME Recorded Nov 25, 2009
From: LABORATOIRES SERONO SA
To: MERCK SERONO SA
Reel/Frame 023569/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →